Advances in Apoptosis Research (Technical Insights)

Publication Date	March 2008
Publisher	Frost & Sullivan
Product Type	Report
Pages
ISBN Number	not applicable
Product Code	FRS00636

Buy this product or for assistance call +44 20 7060 7474

PDF £3,910.00$6504 | €4376

FAX Order above formats by FAX

Summary

This research service provides the latest trends in apoptosis research and future developments

Content

Executive summary
- Scope and methodology
  - Scope of the research service
  - Research methodology
- Insights into apoptosis
  - Apoptosis and its relevance in therapeutics industry
  - Key industry trends in apoptosis
Technical focus on apoptosis phenomenon
- Apoptosis molecular pathways exploration
  - Key categories of molecular pathway proteins
  - Understanding the role of apoptosis proteins
- Apoptosis correlated therapeutic fields
  - Apoptosis functioning in cancer treatment
  - Apoptosis basis connected with neurodegenerative and cardiovascular diseases
- Other cell apoptosis-centered disorders
  - Organ transplantation-associated syndromes
  - Hiv and cell sepsis controlled by apoptosis
- Apoptosis identification techniques
  - Diagnosis and analyzing apoptosis in vivo
  - Potential markers for apoptosis recognition
Assessment of notable technologies involved in drug discovery for apoptosis-based treatment
- Highlights of key developments in the north american region.
  - Triggering apoptosis:innovative oncology drug discovery platform
  - Broad range of clinical development compounds for the treatment of advanced solid tumors
  - Promising small molecule investigational drugs targeting malignancies
  - Novel cancer therapies targeting treatment resistance in oncology patients
  - Tumor-targeting antibodies delivering potent cell-killing agents
  - Cell cycle inhibitors work on cancer through apoptosis
  - Medical device employs apoptosis to reduce cardiac inflammation
  - Bcl-2 emerges as a hot target for cancer therapeutics
- Notable developments in the rest of the world
  - Unique anticancer therapeutics targeting cell death pathways
  - Novel small molecules product targeting established tumor blood vessels
  - Potential treatment paradigm designed for the treatment of solid tumors
  - Pioneering oligonucleotide-based drugs targeting malignant tumors
  - Promising drug development platform with broad oncology applications
  - Advancements in progressive functional pathways studies critical to cancer cells growth
  - Novel class of clinical-stage tumor growth-reducing cancer therapeutics
  - Novel drug therapy for treating solid tumors and blood cancer
  - Highly targeted and potent antiangiogenic cancer therapy
- Universities advancements
  - Miniature stage biomarker-focused translational research
  - Novel research findings identifying combination therapy for cancer
  - Innovative research findings exploiting oncolytic virus therapy for cancer treatment
Technology adoption factor analysis
- Drivers and challenges involved in apoptosis treatment
  - Notable drivers
  - Challenges and restraints
- Patent assessment and analyst insights
  - Patent assessment
  - Analyst's perspective and futuristic trends
  - Entry and expansion strategies
Patent study and database of key participants.
- Patents review
  - Corporate patents
  - Academic patents
- Main participants
  - Companies
  - Universities
Decision support database
- Database tables
  - World r&d expenditure
  - World healthcare expenditure (2002 to 2012)
  - Mortality of bladder cancer--world (2002 to 2012)
  - Incidence of bladder cancer--world (2002 to 2012)
  - Number of active physicians (2002 to 2012)